HRP20220297T1 - Aminoimidazopiridazini kao inhibitori kinaze - Google Patents

Aminoimidazopiridazini kao inhibitori kinaze Download PDF

Info

Publication number
HRP20220297T1
HRP20220297T1 HRP20220297TT HRP20220297T HRP20220297T1 HR P20220297 T1 HRP20220297 T1 HR P20220297T1 HR P20220297T T HRP20220297T T HR P20220297TT HR P20220297 T HRP20220297 T HR P20220297T HR P20220297 T1 HRP20220297 T1 HR P20220297T1
Authority
HR
Croatia
Prior art keywords
pyridazin
acetamidoimidazo
methyl
carboxamide
phenyl
Prior art date
Application number
HRP20220297TT
Other languages
English (en)
Croatian (hr)
Inventor
Michael E. Mertzman
Carolyn Diane Dzierba
Jason M. Guernon
Amy C. HART
Guanglin Luo
John E. Macor
William J. Pitts
Jianliang Shi
Steven H. Spergel
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of HRP20220297T1 publication Critical patent/HRP20220297T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/5025Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HRP20220297TT 2017-10-30 2018-10-29 Aminoimidazopiridazini kao inhibitori kinaze HRP20220297T1 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762578607P 2017-10-30 2017-10-30
US201862626853P 2018-02-06 2018-02-06
EP18804177.6A EP3704118B1 (en) 2017-10-30 2018-10-29 Aminoimidazopyridazines as kinase inhibitors
PCT/US2018/057968 WO2019089442A1 (en) 2017-10-30 2018-10-29 Aminoimidazopyridines as kinase inhibitors

Publications (1)

Publication Number Publication Date
HRP20220297T1 true HRP20220297T1 (hr) 2022-05-13

Family

ID=64332173

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20220297TT HRP20220297T1 (hr) 2017-10-30 2018-10-29 Aminoimidazopiridazini kao inhibitori kinaze

Country Status (23)

Country Link
US (1) US11440913B2 (enExample)
EP (1) EP3704118B1 (enExample)
JP (1) JP7228586B2 (enExample)
KR (1) KR102662197B1 (enExample)
CN (1) CN111566103B (enExample)
AU (1) AU2018361249B2 (enExample)
BR (1) BR112020007557A2 (enExample)
CA (1) CA3080402A1 (enExample)
CY (1) CY1124984T1 (enExample)
DK (1) DK3704118T3 (enExample)
ES (1) ES2905948T3 (enExample)
HR (1) HRP20220297T1 (enExample)
HU (1) HUE058292T2 (enExample)
IL (1) IL274207B2 (enExample)
LT (1) LT3704118T (enExample)
MX (1) MX2020003706A (enExample)
PL (1) PL3704118T3 (enExample)
PT (1) PT3704118T (enExample)
RS (1) RS62974B1 (enExample)
SG (1) SG11202003824PA (enExample)
SI (1) SI3704118T1 (enExample)
SM (1) SMT202200087T1 (enExample)
WO (1) WO2019089442A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018148626A1 (en) 2017-02-13 2018-08-16 Bristol-Myers Squibb Company Aminotriazolopyridines as kinase inhibitors
EA202091777A1 (ru) 2018-01-26 2020-10-14 Бристол-Маерс Сквибб Компани Аминопирролотриазины в качестве ингибиторов киназы
AU2019339355A1 (en) 2018-09-13 2021-05-13 Bristol-Myers Squibb Company Indazole carboxamides as kinase inhibitors
JP7599411B2 (ja) 2018-09-13 2024-12-13 ブリストル-マイヤーズ スクイブ カンパニー 受容体相互作用タンパク質キナーゼ1阻害剤(ripk1)としての1h-インダゾールカルボキサミド
GB201905721D0 (en) 2019-04-24 2019-06-05 Univ Dundee Compounds
KR20220079593A (ko) * 2019-10-03 2022-06-13 브리스톨-마이어스 스큅 컴퍼니 키나제 억제제로서의 인다졸 카르복스아미드
WO2021168521A1 (en) * 2020-02-27 2021-09-02 Anaxis Pharma Pty Ltd Inhibitors of necroptosis
CN114262322A (zh) * 2020-09-16 2022-04-01 中国科学院上海有机化学研究所 一类细胞程序性坏死抑制剂及其制备方法和用途
JP2023544892A (ja) * 2020-10-13 2023-10-25 ザ・ジョンズ・ホプキンス・ユニバーシティー 置換4-([1,2,4]トリアゾロ[1,5-a]ピリジン-6-イル)チオフェン-2-カルボキサミド誘導体及びその使用
AR123793A1 (es) * 2020-10-19 2023-01-11 Bristol Myers Squibb Co Compuestos de triazolopiridinilo como inhibidores de quinasas
CN120530112A (zh) * 2022-12-30 2025-08-22 广州市联瑞制药有限公司 双环类化合物及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070978A1 (es) * 2006-02-14 2007-11-15 Novartis Ag COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
US7820665B2 (en) 2007-12-19 2010-10-26 Amgen Inc. Imidazopyridazine inhibitors of PI3 kinase for cancer treatment
JP5589003B2 (ja) * 2009-02-04 2014-09-10 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 脂質障害のような代謝疾患の処置のために有用な[1,3]オキサジン−2−オンの誘導体
EP2865671B1 (en) 2012-06-22 2017-11-01 Sumitomo Chemical Company, Ltd Fused heterocyclic compound
EP2897949B1 (en) 2012-09-18 2018-01-10 Bristol-Myers Squibb Company Iap antagonists
ES2749467T3 (es) 2012-11-20 2020-03-20 Biogen Ma Inc Agentes moduladores de S1p y/o ATX
WO2014144455A1 (en) 2013-03-15 2014-09-18 Epizyme, Inc. 1 -phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
CA2914668A1 (en) 2013-06-10 2014-12-18 Volker Schulze Novel compounds for the treatment of cancer
RU2017109122A (ru) 2014-08-21 2018-09-21 Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Способы лечения с использованием гетероциклических амидов в качестве ингибиторов киназы
BR112018072552A8 (pt) 2016-05-05 2023-03-14 Lysosomal Therapeutics Inc Compostos de imidazo [1,2-b]piridazinas e imidazo [1,5-b] piridazinas substituídas, composição farmacêutica que os compreende e seu uso no tratamento de distúrbios médicos
WO2018017435A1 (en) 2016-07-22 2018-01-25 Accro Bioscience Inc. Heteroaryl compounds as inhibitors of necrosis, composition and application thereof
WO2018148626A1 (en) 2017-02-13 2018-08-16 Bristol-Myers Squibb Company Aminotriazolopyridines as kinase inhibitors
EA202091777A1 (ru) 2018-01-26 2020-10-14 Бристол-Маерс Сквибб Компани Аминопирролотриазины в качестве ингибиторов киназы
AU2019339355A1 (en) 2018-09-13 2021-05-13 Bristol-Myers Squibb Company Indazole carboxamides as kinase inhibitors
JP7599411B2 (ja) 2018-09-13 2024-12-13 ブリストル-マイヤーズ スクイブ カンパニー 受容体相互作用タンパク質キナーゼ1阻害剤(ripk1)としての1h-インダゾールカルボキサミド
WO2020097400A1 (en) * 2018-11-07 2020-05-14 Dana-Farber Cancer Institute, Inc. Imidazopyridine derivatives and aza-imidazopyridine derivatives as janus kinase 2 inhibitors and uses thereof

Also Published As

Publication number Publication date
BR112020007557A2 (pt) 2020-09-24
WO2019089442A1 (en) 2019-05-09
EP3704118A1 (en) 2020-09-09
SG11202003824PA (en) 2020-05-28
KR102662197B1 (ko) 2024-04-29
DK3704118T3 (da) 2022-03-14
AU2018361249B2 (en) 2022-08-25
JP2021501179A (ja) 2021-01-14
PL3704118T3 (pl) 2022-04-04
ES2905948T3 (es) 2022-04-12
SMT202200087T1 (it) 2022-03-21
IL274207A (en) 2020-06-30
IL274207B2 (en) 2023-04-01
CY1124984T1 (el) 2023-01-05
CA3080402A1 (en) 2019-05-09
CN111566103A (zh) 2020-08-21
US20200277296A1 (en) 2020-09-03
WO2019089442A8 (en) 2019-06-27
SI3704118T1 (sl) 2022-04-29
HUE058292T2 (hu) 2022-07-28
US11440913B2 (en) 2022-09-13
AU2018361249A1 (en) 2020-06-11
PT3704118T (pt) 2022-02-14
KR20200078591A (ko) 2020-07-01
JP7228586B2 (ja) 2023-02-24
EP3704118B1 (en) 2022-01-12
IL274207B (en) 2022-12-01
CN111566103B (zh) 2023-06-23
MX2020003706A (es) 2020-07-22
LT3704118T (lt) 2022-02-25
RS62974B1 (sr) 2022-03-31

Similar Documents

Publication Publication Date Title
HRP20220297T1 (hr) Aminoimidazopiridazini kao inhibitori kinaze
JP2021501179A5 (enExample)
HRP20212000T1 (hr) Aminotriazolopiridini kao inhibitori kinaze
JP2019507179A5 (enExample)
RU2454405C2 (ru) Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина
RU2010140668A (ru) Ингибиторы активности протеинтирозинкиназы
RU2010115574A (ru) Замещенные амиды, фармацевтическая композиция на их основе, способ лечения заболевания, чувствительного к btk, способ повышения чувствительности раковых клеток к химиотерапии, способ уменьшения ошибок при приеме лекарства и улучшения соблюдения схемы лечения, способ ингибирования гидролиза атф, способ определения присутствия btk в образце и способ ингибирования активности в-клеток
HRP20161011T1 (hr) Aril dihidropiridinoni i piperidinoni kao inhibitori mgat2
JP2010540452A5 (enExample)
IL276575B2 (en) Inhibitors of btk and mutants thereof
IL264982B (en) (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
RU2000128036A (ru) Амидиновые соединения
HRP20191821T1 (hr) Antiproliferativni spojevi i načini njihove uporabe
RU2013143028A (ru) Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ
JP2009529059A5 (enExample)
JP2013507449A5 (enExample)
HRP20140309T1 (hr) SUPSTITUIRANI SPOJEVI PIRAZOLO[1,5-a]PIRIMIDINA KAO INHIBITORI TRK KINAZE
HRP20130220T1 (hr) Modulatori indolamin 2,3-dioksigenaze i postupci upotrebe istih
RU2005121897A (ru) Производные аминоиндазолов и их применение в качестве ингибиторов киназ
RU2013151174A (ru) Замещенные пиримидинилпирролы, активные в качестве ингибиторов киназы
RU2017145650A (ru) Ингибиторы тирозинкиназы брутона
RU2005109561A (ru) Новые производные аминоиндазолов в качестве лекарственных средств и содержащие их фармацевтические композиции
RU2009101911A (ru) Производные пиридина и пиразина в качестве ингибиторов mnk-киназы
JP2012506446A5 (enExample)
HRP20170357T1 (hr) Sastavi i postupci za liječenje poremećaja zbog konzumacije alkohola, bolova i ostalih bolesti